<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01180920</url>
  </required_header>
  <id_info>
    <org_study_id>HUM00038150</org_study_id>
    <secondary_id>5K23DE019872</secondary_id>
    <nct_id>NCT01180920</nct_id>
  </id_info>
  <brief_title>The Importance of Periostin in Periodontal Health and Disease</brief_title>
  <official_title>The Importance of Periostin in Periodontal Health and Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Michigan</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institutes of Health (NIH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Institute of Dental and Craniofacial Research (NIDCR)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Michigan</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of this study is to determine the clinical importance of Periostin in oral health
      and disease. The long-term goal will be to develop practical applications for the diagnosis,
      treatment, prevention and cure of human periodontal diseases.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      It is hypothesized that Periostin levels are decreased during periodontal diseases, thereby,
      elevating the hosts' susceptibility to periodontal breakdown. The specific aims are the
      following; To determine if Periostin is a biomarker of periodontal disease, and To evaluate
      Periostin in periodontal tissue healing and homeostasis by harvesting healthy or diseased
      tissue from 22 patients requiring periodontal surgery.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2011</start_date>
  <completion_date type="Actual">February 2013</completion_date>
  <primary_completion_date type="Actual">February 2013</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>To determine whether the expression of Periostin within the periodontal tissues is affected in periodontal disease progression in-vivo and whether Periostin levels are associated with disease susceptibility.</measure>
    <time_frame>Baseline</time_frame>
    <description>Periostin levels from gingival crevicular fluid (GCF), saliva, serum and tissue will be analyzed in both health and disease. Total RNA and protein extracts will be isolated and utilized for relative quantitative measurements.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>explore the expression dynamics of Periostin during periodontal healing in healthy and diseased periodontia.</measure>
    <time_frame>8wks</time_frame>
    <description>A longitudinal study will also be performed to evaluate Periostin levels in GCF/wound fluids and saliva over time during periodontal tissue healing and homeostasis.</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">22</enrollment>
  <condition>Periodontal Disease</condition>
  <condition>Non-diseased Patients</condition>
  <arm_group>
    <arm_group_label>Periodontal disease</arm_group_label>
    <description>11 patients with periodontal disease, specifically generalized chronic or aggressive periodontitis will be selected. In general, the disease group will be comprised of subjects that need an open flap procedure.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy periodontium</arm_group_label>
    <description>11 patients without periodontal disease will be selected. In general, the healthy group will be comprised of subjects that are requiring a gingivectomy or crown lengthening procedure.</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Each patient will be have 5ml of blood collected at 3 different visits. Saliva, and gingival
      crevicular fluid will also be collected at 7-8 visits during the study. Gingival tissue will
      be collected on the day of surgery.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        This study will have a sample size of 22 subjects: 11 periodontally healthy and 11 with
        periodontal disease.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Inclusion criteria for diseased subjects:

          -  Diagnosis of generalized chronic or aggressive periodontitis

          -  At least four periodontal sites with probing depth (PD) ≥6 mm, evidence of clinical
             attachment loss (CAL), and bleeding on probing (BOP). Inclusion criteria for healthy
             individuals will include PD &lt;4 mm, no evidence of attachment loss, and &lt;10% of sites
             with BOP

          -  Need an open flap procedure

        Inclusion criteria for non-diseased subjects:

          -  Subjects requiring a gingivectomy or crown lengthening procedure

        Exclusion Criteria:

          -  History of alcoholism or drug abuse

          -  Medical conditions that may affect the outcome such as autoimmune diseases, diabetes,
             immunocompromised subjects, neurologic or psychiatric disorders, systemic infections,
             etc.

          -  Chronic medications known to affect the periodontal status (calcium antagonists,
             anticonvulsives, immunosuppressives, anti-inflammatory medications, Depo-Provera
             contraceptive injection users, new oral contraceptives users within 3 months of
             baseline or subjects that are planning on, starting oral contraceptives during the
             study.

          -  Antibiotic therapy within 3 months of the baseline visit, and/or antibiotic therapy
             needed for infective endocarditis prophylaxis.

          -  Current use or quit smoking less than one year ago with a pack-year history of more
             than or equal to 10.

          -  Untreated cavities
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hector Rios, MS, DDS</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Michigan</affiliation>
  </overall_official>
  <overall_official>
    <last_name>William V Giannobile, DDS, DMSc</last_name>
    <role>Study Director</role>
    <affiliation>University of Michigan</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Michigan Center for Oral Health Research</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48106</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Needleman I, McGrath C, Floyd P, Biddle A. Impact of oral health on the life quality of periodontal patients. J Clin Periodontol. 2004 Jun;31(6):454-7.</citation>
    <PMID>15142215</PMID>
  </reference>
  <reference>
    <citation>Socransky SS, Haffajee AD, Smith C, Martin L, Haffajee JA, Uzel NG, Goodson JM. Use of checkerboard DNA-DNA hybridization to study complex microbial ecosystems. Oral Microbiol Immunol. 2004 Dec;19(6):352-62.</citation>
    <PMID>15491460</PMID>
  </reference>
  <reference>
    <citation>Götz W, Heinen M, Lossdörfer S, Jäger A. Immunohistochemical localization of components of the insulin-like growth factor system in human permanent teeth. Arch Oral Biol. 2006 May;51(5):387-95.</citation>
    <PMID>16321360</PMID>
  </reference>
  <reference>
    <citation>Lee A, Schneider G, Finkelstein M, Southard T. Root resorption: the possible role of extracellular matrix proteins. Am J Orthod Dentofacial Orthop. 2004 Aug;126(2):173-7.</citation>
    <PMID>15316471</PMID>
  </reference>
  <reference>
    <citation>Yang YQ, Li XT, Rabie AB, Fu MK, Zhang D. Human periodontal ligament cells express osteoblastic phenotypes under intermittent force loading in vitro. Front Biosci. 2006 Jan 1;11:776-81.</citation>
    <PMID>16146769</PMID>
  </reference>
  <reference>
    <citation>Rios HF, Ma D, Xie Y, Giannobile WV, Bonewald LF, Conway SJ, Feng JQ. Periostin is essential for the integrity and function of the periodontal ligament during occlusal loading in mice. J Periodontol. 2008 Aug;79(8):1480-90. doi: 10.1902/jop.2008.070624 .</citation>
    <PMID>18672999</PMID>
  </reference>
  <reference>
    <citation>Hamilton DW. Functional role of periostin in development and wound repair: implications for connective tissue disease. J Cell Commun Signal. 2008 Jun;2(1-2):9-17. doi: 10.1007/s12079-008-0023-5. Epub 2008 Jul 20.</citation>
    <PMID>18642132</PMID>
  </reference>
  <reference>
    <citation>Horiuchi K, Amizuka N, Takeshita S, Takamatsu H, Katsuura M, Ozawa H, Toyama Y, Bonewald LF, Kudo A. Identification and characterization of a novel protein, periostin, with restricted expression to periosteum and periodontal ligament and increased expression by transforming growth factor beta. J Bone Miner Res. 1999 Jul;14(7):1239-49.</citation>
    <PMID>10404027</PMID>
  </reference>
  <reference>
    <citation>Wilde J, Yokozeki M, Terai K, Kudo A, Moriyama K. The divergent expression of periostin mRNA in the periodontal ligament during experimental tooth movement. Cell Tissue Res. 2003 Jun;312(3):345-51. Epub 2003 May 22.</citation>
    <PMID>12761672</PMID>
  </reference>
  <reference>
    <citation>Kiili M, Cox SW, Chen HY, Wahlgren J, Maisi P, Eley BM, Salo T, Sorsa T. Collagenase-2 (MMP-8) and collagenase-3 (MMP-13) in adult periodontitis: molecular forms and levels in gingival crevicular fluid and immunolocalisation in gingival tissue. J Clin Periodontol. 2002 Mar;29(3):224-32. Erratum in: J Clin Periodontol. 2004 Feb;31(2):149. Chen, HW [corrected to Chen, HY].</citation>
    <PMID>11940142</PMID>
  </reference>
  <reference>
    <citation>Jee SW, Wang S, Kapila YL. Specific pro-apoptotic fibronectin fragments modulate proteinase expression in periodontal ligament cells. J Periodontol. 2004 Apr;75(4):523-30.</citation>
    <PMID>15152815</PMID>
  </reference>
  <verification_date>December 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 10, 2010</study_first_submitted>
  <study_first_submitted_qc>August 11, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 12, 2010</study_first_posted>
  <last_update_submitted>December 1, 2014</last_update_submitted>
  <last_update_submitted_qc>December 1, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 2, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Michigan</investigator_affiliation>
    <investigator_full_name>Hector Rios</investigator_full_name>
    <investigator_title>Assistant Professor of Periodontal and Oral Medicine</investigator_title>
  </responsible_party>
  <keyword>Dental</keyword>
  <keyword>Periodontal</keyword>
  <keyword>Surgery</keyword>
  <keyword>Gums</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Periodontal Diseases</mesh_term>
    <mesh_term>Gingival Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

